Oncology News

In a roundtable format, experts gathered to discuss the latest research on coffee and liver disease, which indicate that drinking approximately three to five cups per day is associated with a reduced risk for hepatocellular carcinoma, cirrhosis and fibrosis.

Researchers observed that nonalcoholic fatty liver disease was associated with hepatocellular carcinoma in general and with colorectal cancer in men and breast cancer in women, according to recently published data.

Although clinically effective, the use of regorafenib as second-line therapy for hepatocellular carcinoma did not appear cost-effective, according to study results.

Long-term aspirin use significantly reduced the incidence of many cancers, but was especially protective against gastrointestinal cancers, according to new research presented at UEG Week.

WASHINGTON — Reaching sustained virologic response with direct-acting antivirals reduced the occurrence of hepatocellular carcinoma by 71%, but all treatments that cleared the virus saw a similar reduction in risk, according to a presenter at The Liver Meeting 2017.

WASHINGTON — Through treatment of hepatitis C genotype 1 with direct-acting antivirals, significant direct and indirect cost savings may arise due to fewer cases of hepatocellular carcinoma and decompensated cirrhosis, according to results of a simulated model presented at The Liver Meeting 2017. 

WASHINGTON — Beginning Friday, October 20, Healio Gastroenterology and Liver Disease will provide live coverage from the The Liver Meeting 2017.

Researchers found no evidence of increased rates of de novo or recurrent hepatocellular carcinoma following treatment with direct-acting antivirals compared with patients treated with interferon therapy, according to a presentation at the World Congress of Gastroenterology at ACG 2017.

A phase 3 trial designed to compare cabozantinib with placebo for patients with advanced hepatocellular carcinoma met its primary endpoint of OS.

A SEER analysis published this summer revealed staggering statistics about liver cancer in the United States.